Ovascience Inc (OVAS) 44.32 $OVAS
'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head
at The Street - Thu Feb 05, 5:00AM CST
Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.
AMBA: 50.71 (-4.46), BX: 37.40 (+0.49), VMW: 84.68 (+1.06), OVAS: 44.32 (+0.87), NBR: 12.73 (+0.52), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), HAIN: 59.48 (+0.45), SSYS: 67.16 (-0.34), NPSP: 45.88 (+0.03), PPC: 26.75 (+0.77), FLT: 150.37 (+1.15), MD: 71.32 (-0.06)
Blackstone Is An Excellent Holding - Cramer's Lightning Round (2/4/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Thu Feb 05, 4:21AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 4. Bullish Calls: Alaska Air (NYSE: ALK ): " I like Alaska Air and I like Southwest Airlines (NYSE: LUV )." OvaScience (NASDAQ:...
AMBA: 50.71 (-4.46), BX: 37.40 (+0.49), OVAS: 44.32 (+0.87), VMW: 84.68 (+1.06), NBR: 12.73 (+0.52), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), SSYS: 67.16 (-0.34), PPC: 26.75 (+0.77), NPSP: 45.88 (+0.03), FLT: 150.37 (+1.15), MD: 71.32 (-0.06)
Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead
at The Street - Wed Feb 04, 7:26PM CST
Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.
KMI: 41.97 (+0.21), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), VMW: 84.68 (+1.06), OVAS: 44.32 (+0.87), NKE: 92.04 (+0.04), FRPT: 16.78 (-0.12), NBR: 12.73 (+0.52), WYNN: 159.34 (+4.62), RL: 135.20 (-0.60), UPS: 101.79 (+0.38), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), WHR: 213.23 (+0.18), JNJ: 99.62 (+1.18), BC: 55.30 (+0.61), CMG: 674.89 (+4.60), SSYS: 67.16 (-0.34), PPC: 26.75 (+0.77), NPSP: 45.88 (+0.03), DG: 68.82 (+1.23), CAT: 85.13 (+1.60), MD: 71.32 (-0.06), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), WFM: 56.15 (-0.15), AMBA: 50.71 (-4.46), NSC: 109.91 (-0.17), MCK: 224.89 (+0.12), NUE: 48.90 (+0.55), HAL: 44.19 (+1.42), DIS: 104.17 (+0.59), COP: 69.88 (+1.84), BMY: 60.04 (+0.56), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), CELG: 115.88 (+0.16), HAIN: 59.48 (+0.45), TTWO: 28.40 (+0.96), GILD: 101.90 (+1.10), MCD: 95.65 (+0.56), FLT: 150.37 (+1.15), PG: 85.90 (-0.13)
OvaScience to Present at Leerink Global Healthcare Conference
Business Wire - Wed Feb 04, 7:30AM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015 at 1:25 pm ET at the Waldorf Astoria hotel in New York City.
OVAS: 44.32 (+0.87)
5 Stocks Poised for Breakouts: Twitter, Apple and More
at The Street - Fri Jan 23, 6:00AM CST
These stocks look ready to break out and trade higher from current levels.
ASPN: 7.96 (-0.08), EAC: 7.19 (+0.13), OVAS: 44.32 (+0.87), TWTR: 48.50 (+0.55), AAPL: 127.08 (+0.62)
5 Stocks Insiders Love Right Now: eHealth, Worthington Industries and More
at The Street - Wed Jan 21, 6:00AM CST
Insiders at these comapnies have been snapping up shares of their own stocks lately.
OVAS: 44.32 (+0.87), CDNA: 6.30 (-0.14), WOR: 31.13 (+0.33), FPRX: 24.63 (+0.63), EHTH: 10.91 (-0.04)
OvaScience's Fertility Treatment Shows Promise
TipRanks - at Seeking Alpha - Tue Jan 20, 3:25PM CST
By Sarah Roden OvaScience (NASDAQ: OVAS ) is still testing its Augment Treatment, but analysts seem optimistic about recent results. OvaScience focuses on developing fertility treatments. The company's first available treatment is Augment, which...
OVAS: 44.32 (+0.87)
InsiderInsights.com Daily Round Up 1/15/15: ETE, OVAS, TWMC, GPC
InsiderInsights - at Seeking Alpha - Thu Jan 15, 11:44PM CST
TWMC: 3.67 (+0.12), OVAS: 44.32 (+0.87), GPC: 97.01 (+0.22), GNCMA: 14.49 (-0.14), UPLD: 7.22 (-0.02), ETE: 59.75 (+1.45), FUND: 7.47 (+0.05), SRE: 105.56 (-1.11), GOOG: 549.01 (+6.08), MFRM: 62.22 (-0.12), TNET: 36.49 (+0.76), BH: 416.41 (-1.55), WIW: 11.29 (unch), JPM: 59.67 (+0.10), LNKD: 269.00 (+1.83), CDNA: 6.30 (-0.14), SGNT: 27.75 (-0.41), AAVL: 36.29 (+0.01), ALCO: 45.40 (+1.44)
OvaScience Announces Closing of $132 Million Public Offering of Common Stock including Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire - Tue Jan 13, 3:01PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today the closing of its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 345,000 shares of common stock at the public offering price of $50.00 per share. The exercise of the underwriters' option brought the total number of shares of common stock sold by OvaScience to 2,645,000 shares and increased the total gross proceeds raised in this offering to $132.3 million, before deducting the underwriting discounts, commissions and estimated expenses.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
OvaScience to Present at the J.P. Morgan Healthcare Conference
Business Wire - Fri Jan 09, 7:30AM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 3:30 pm local time at the Westin St. Francis in San Francisco.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
OvaScience (OVAS) Shows Strength: Stock Moves 8.1% Up - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 7:51AM CST
OvaScience, Inc. (OVAS) was a big mover last session with its shares rising over 8% on the day.
OVAS: 44.32 (+0.87), AMAG: 41.49 (+0.23)
OvaScience Prices $115 Million Public Offering of Common Stock
Business Wire - Wed Jan 07, 6:24PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that it has priced its previously announced underwritten public offering of 2,300,000 shares of its common stock at a public offering price of $50 per share. Gross proceeds to OvaScience from this offering are expected to be approximately $115 million, and OvaScience intends to use the net proceeds from this offering to fund the expanded international launch of the AUGMENT(SM) treatment, planned international launch of the OvaPrime(SM) treatment, development of the OvaTure(SM) treatment and pursuit of a potential accelerated development pathway, establishment of an international headquarters in the United Kingdom and additional subsidiaries, and for other general corporate purposes.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
Jim Cramer's Top Stock Picks: WFC PPG JCP OVAS MCD
at The Street - Wed Jan 07, 5:00AM CST
Cramer says PPG and J.C. Penney benefit from lower oil prices and sees growth coming for McDonald's.
OVAS: 44.32 (+0.87), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), WFC: 55.33 (+0.47), PPG: 236.77 (+3.74)
Cramer's Mad Money - Best Biotechs Of 2014 (1/6/15)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Jan 07, 4:38AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday January 6. Best Biotechs of 2014: Isis Pharmaceuticals (NASDAQ: ISIS ), BioMarin (NASDAQ: BMRN ), OvaScience (NASDAQ: OVAS ), Agios (NASDAQ: AGIO ),...
BLUE: 90.70 (+0.93), GE: 25.15 (+0.26), BMRN: 100.76 (+1.98), OVAS: 44.32 (+0.87), XOM: 93.37 (+1.00), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), GLUU: 5.12 (+0.14), LUV: 43.30 (-0.20), T: 34.66 (+0.05), TTWO: 28.40 (+0.96), GT: 25.91 (-0.30), SAVE: 79.32 (-0.80), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), IBM: 160.40 (+1.88), AAL: 48.39 (+0.51), MCD: 95.65 (+0.56), RCPT: 115.83 (-0.66), AGI: 5.78 (+0.03), TWTR: 48.50 (+0.55), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21)
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
at The Street - Tue Jan 06, 7:25PM CST
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
TSLA: 203.77 (+0.89), GE: 25.15 (+0.26), OVAS: 44.32 (+0.87), NMM: 12.37 (+0.24), XOM: 93.37 (+1.00), T: 34.66 (+0.05), ESPR: 67.13 (-0.33), IBM: 160.40 (+1.88), IRE: 14.54 (+0.81), DTV: 87.51 (-0.32), PTCT: 53.37 (-0.74), RCPT: 115.83 (-0.66), TEG: 75.56 (-1.61), PPG: 236.77 (+3.74), WAG: 76.05 (-0.49), BLUE: 90.70 (+0.93), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), RAD: 8.34 (+0.25), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), ACHN: 10.89 (-0.20), JCP: 8.05 (+0.14), CVS: 102.63 (-0.37), MCD: 95.65 (+0.56), AGIO: 118.55 (+0.11), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21), FOLD: 8.36 (-0.11)
OvaScience proceeds on secondary equity offering
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:24PM CST
OVAS: 44.32 (+0.87)
OvaScience Announces Proposed Public Offering of Common Stock
Business Wire - Tue Jan 06, 3:01PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today it has commenced an underwritten public offering of up to $85 million of shares of its common stock. OvaScience intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of the common stock offered in the public offering. All of the shares in the offering will be sold by OvaScience.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
These 3 Biotech Stocks Tripled Investors' Money in 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Jan 04, 11:32AM CST
Life-changing financial gains are usually generated over the long haul, not in one year. However, sometimes stocks can put up eye-popping returns over a short period of time and when they do they can have a huge impact on investor's portfolios. For...
BLUE: 90.70 (+0.93), OVAS: 44.32 (+0.87), AGIO: 118.55 (+0.11)
How These 3 Stocks Doubled Investors' Money in Q4
Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 03, 9:31AM CST
Source: Flickr user Tax Credits Most of the time, life-changing financial gains are generated over the long haul, not in the blink of an eye. However, sometimes stocks can put up jaw-dropping returns over a short period of time too. For example,...
BLUE: 90.70 (+0.93), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), OVAS: 44.32 (+0.87), GILD: 101.90 (+1.10), RGLS: 16.85 (-0.13), CELG: 115.88 (+0.16)
Biotech Stocks 2014: The Best, Worst and Fastest-Growing
at The Street - Fri Jan 02, 7:33AM CST
Once again, biotech stocks greatly outperformed the broader market in 2014.
BLUE: 90.70 (+0.93), OVAS: 44.32 (+0.87), ACHN: 10.89 (-0.20), RCPT: 115.83 (-0.66), AGIO: 118.55 (+0.11)
'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head
at The Street - Thu Feb 05, 5:00AM CST
Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.
AMBA: 50.71 (-4.46), BX: 37.40 (+0.49), VMW: 84.68 (+1.06), OVAS: 44.32 (+0.87), NBR: 12.73 (+0.52), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), HAIN: 59.48 (+0.45), SSYS: 67.16 (-0.34), NPSP: 45.88 (+0.03), PPC: 26.75 (+0.77), FLT: 150.37 (+1.15), MD: 71.32 (-0.06)
Blackstone Is An Excellent Holding - Cramer's Lightning Round (2/4/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Thu Feb 05, 4:21AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 4. Bullish Calls: Alaska Air (NYSE: ALK ): " I like Alaska Air and I like Southwest Airlines (NYSE: LUV )." OvaScience (NASDAQ:...
AMBA: 50.71 (-4.46), BX: 37.40 (+0.49), OVAS: 44.32 (+0.87), VMW: 84.68 (+1.06), NBR: 12.73 (+0.52), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), SSYS: 67.16 (-0.34), PPC: 26.75 (+0.77), NPSP: 45.88 (+0.03), FLT: 150.37 (+1.15), MD: 71.32 (-0.06)
Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead
at The Street - Wed Feb 04, 7:26PM CST
Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.
KMI: 41.97 (+0.21), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), VMW: 84.68 (+1.06), OVAS: 44.32 (+0.87), NKE: 92.04 (+0.04), FRPT: 16.78 (-0.12), NBR: 12.73 (+0.52), WYNN: 159.34 (+4.62), RL: 135.20 (-0.60), UPS: 101.79 (+0.38), SLB: 88.38 (+2.42), LUV: 43.30 (-0.20), WHR: 213.23 (+0.18), JNJ: 99.62 (+1.18), BC: 55.30 (+0.61), CMG: 674.89 (+4.60), SSYS: 67.16 (-0.34), PPC: 26.75 (+0.77), NPSP: 45.88 (+0.03), DG: 68.82 (+1.23), CAT: 85.13 (+1.60), MD: 71.32 (-0.06), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), WFM: 56.15 (-0.15), AMBA: 50.71 (-4.46), NSC: 109.91 (-0.17), MCK: 224.89 (+0.12), NUE: 48.90 (+0.55), HAL: 44.19 (+1.42), DIS: 104.17 (+0.59), COP: 69.88 (+1.84), BMY: 60.04 (+0.56), ALK: 62.56 (-0.19), HPQ: 38.56 (+0.19), CELG: 115.88 (+0.16), HAIN: 59.48 (+0.45), TTWO: 28.40 (+0.96), GILD: 101.90 (+1.10), MCD: 95.65 (+0.56), FLT: 150.37 (+1.15), PG: 85.90 (-0.13)
OvaScience to Present at Leerink Global Healthcare Conference
Business Wire - Wed Feb 04, 7:30AM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015 at 1:25 pm ET at the Waldorf Astoria hotel in New York City.
OVAS: 44.32 (+0.87)
5 Stocks Poised for Breakouts: Twitter, Apple and More
at The Street - Fri Jan 23, 6:00AM CST
These stocks look ready to break out and trade higher from current levels.
ASPN: 7.96 (-0.08), EAC: 7.19 (+0.13), OVAS: 44.32 (+0.87), TWTR: 48.50 (+0.55), AAPL: 127.08 (+0.62)
5 Stocks Insiders Love Right Now: eHealth, Worthington Industries and More
at The Street - Wed Jan 21, 6:00AM CST
Insiders at these comapnies have been snapping up shares of their own stocks lately.
OVAS: 44.32 (+0.87), CDNA: 6.30 (-0.14), WOR: 31.13 (+0.33), FPRX: 24.63 (+0.63), EHTH: 10.91 (-0.04)
OvaScience's Fertility Treatment Shows Promise
TipRanks - at Seeking Alpha - Tue Jan 20, 3:25PM CST
By Sarah Roden OvaScience (NASDAQ: OVAS ) is still testing its Augment Treatment, but analysts seem optimistic about recent results. OvaScience focuses on developing fertility treatments. The company's first available treatment is Augment, which...
OVAS: 44.32 (+0.87)
InsiderInsights.com Daily Round Up 1/15/15: ETE, OVAS, TWMC, GPC
InsiderInsights - at Seeking Alpha - Thu Jan 15, 11:44PM CST
TWMC: 3.67 (+0.12), OVAS: 44.32 (+0.87), GPC: 97.01 (+0.22), GNCMA: 14.49 (-0.14), UPLD: 7.22 (-0.02), ETE: 59.75 (+1.45), FUND: 7.47 (+0.05), SRE: 105.56 (-1.11), GOOG: 549.01 (+6.08), MFRM: 62.22 (-0.12), TNET: 36.49 (+0.76), BH: 416.41 (-1.55), WIW: 11.29 (unch), JPM: 59.67 (+0.10), LNKD: 269.00 (+1.83), CDNA: 6.30 (-0.14), SGNT: 27.75 (-0.41), AAVL: 36.29 (+0.01), ALCO: 45.40 (+1.44)
OvaScience Announces Closing of $132 Million Public Offering of Common Stock including Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire - Tue Jan 13, 3:01PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today the closing of its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 345,000 shares of common stock at the public offering price of $50.00 per share. The exercise of the underwriters' option brought the total number of shares of common stock sold by OvaScience to 2,645,000 shares and increased the total gross proceeds raised in this offering to $132.3 million, before deducting the underwriting discounts, commissions and estimated expenses.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
OvaScience to Present at the J.P. Morgan Healthcare Conference
Business Wire - Fri Jan 09, 7:30AM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 3:30 pm local time at the Westin St. Francis in San Francisco.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
OvaScience (OVAS) Shows Strength: Stock Moves 8.1% Up - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 7:51AM CST
OvaScience, Inc. (OVAS) was a big mover last session with its shares rising over 8% on the day.
OVAS: 44.32 (+0.87), AMAG: 41.49 (+0.23)
OvaScience Prices $115 Million Public Offering of Common Stock
Business Wire - Wed Jan 07, 6:24PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that it has priced its previously announced underwritten public offering of 2,300,000 shares of its common stock at a public offering price of $50 per share. Gross proceeds to OvaScience from this offering are expected to be approximately $115 million, and OvaScience intends to use the net proceeds from this offering to fund the expanded international launch of the AUGMENT(SM) treatment, planned international launch of the OvaPrime(SM) treatment, development of the OvaTure(SM) treatment and pursuit of a potential accelerated development pathway, establishment of an international headquarters in the United Kingdom and additional subsidiaries, and for other general corporate purposes.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
Jim Cramer's Top Stock Picks: WFC PPG JCP OVAS MCD
at The Street - Wed Jan 07, 5:00AM CST
Cramer says PPG and J.C. Penney benefit from lower oil prices and sees growth coming for McDonald's.
OVAS: 44.32 (+0.87), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), WFC: 55.33 (+0.47), PPG: 236.77 (+3.74)
Cramer's Mad Money - Best Biotechs Of 2014 (1/6/15)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Jan 07, 4:38AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday January 6. Best Biotechs of 2014: Isis Pharmaceuticals (NASDAQ: ISIS ), BioMarin (NASDAQ: BMRN ), OvaScience (NASDAQ: OVAS ), Agios (NASDAQ: AGIO ),...
BLUE: 90.70 (+0.93), GE: 25.15 (+0.26), BMRN: 100.76 (+1.98), OVAS: 44.32 (+0.87), XOM: 93.37 (+1.00), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), GLUU: 5.12 (+0.14), LUV: 43.30 (-0.20), T: 34.66 (+0.05), TTWO: 28.40 (+0.96), GT: 25.91 (-0.30), SAVE: 79.32 (-0.80), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), IBM: 160.40 (+1.88), AAL: 48.39 (+0.51), MCD: 95.65 (+0.56), RCPT: 115.83 (-0.66), AGI: 5.78 (+0.03), TWTR: 48.50 (+0.55), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21)
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
at The Street - Tue Jan 06, 7:25PM CST
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
TSLA: 203.77 (+0.89), GE: 25.15 (+0.26), OVAS: 44.32 (+0.87), NMM: 12.37 (+0.24), XOM: 93.37 (+1.00), T: 34.66 (+0.05), ESPR: 67.13 (-0.33), IBM: 160.40 (+1.88), IRE: 14.54 (+0.81), DTV: 87.51 (-0.32), PTCT: 53.37 (-0.74), RCPT: 115.83 (-0.66), TEG: 75.56 (-1.61), PPG: 236.77 (+3.74), WAG: 76.05 (-0.49), BLUE: 90.70 (+0.93), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), RAD: 8.34 (+0.25), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), ACHN: 10.89 (-0.20), JCP: 8.05 (+0.14), CVS: 102.63 (-0.37), MCD: 95.65 (+0.56), AGIO: 118.55 (+0.11), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21), FOLD: 8.36 (-0.11)
OvaScience proceeds on secondary equity offering
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:24PM CST
OVAS: 44.32 (+0.87)
OvaScience Announces Proposed Public Offering of Common Stock
Business Wire - Tue Jan 06, 3:01PM CST
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today it has commenced an underwritten public offering of up to $85 million of shares of its common stock. OvaScience intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of the common stock offered in the public offering. All of the shares in the offering will be sold by OvaScience.
OVAS: 44.32 (+0.87), JPM: 59.67 (+0.10)
These 3 Biotech Stocks Tripled Investors' Money in 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Jan 04, 11:32AM CST
Life-changing financial gains are usually generated over the long haul, not in one year. However, sometimes stocks can put up eye-popping returns over a short period of time and when they do they can have a huge impact on investor's portfolios. For...
BLUE: 90.70 (+0.93), OVAS: 44.32 (+0.87), AGIO: 118.55 (+0.11)
How These 3 Stocks Doubled Investors' Money in Q4
Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 03, 9:31AM CST
Source: Flickr user Tax Credits Most of the time, life-changing financial gains are generated over the long haul, not in the blink of an eye. However, sometimes stocks can put up jaw-dropping returns over a short period of time too. For example,...
BLUE: 90.70 (+0.93), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), OVAS: 44.32 (+0.87), GILD: 101.90 (+1.10), RGLS: 16.85 (-0.13), CELG: 115.88 (+0.16)
Biotech Stocks 2014: The Best, Worst and Fastest-Growing
at The Street - Fri Jan 02, 7:33AM CST
Once again, biotech stocks greatly outperformed the broader market in 2014.
BLUE: 90.70 (+0.93), OVAS: 44.32 (+0.87), ACHN: 10.89 (-0.20), RCPT: 115.83 (-0.66), AGIO: 118.55 (+0.11)
